SLNO 241220 55.00C (SLNO241220C55000) Stock Options, News & Quotes

US OptionsDetailed Quotes

SLNO241220C55000

Watchlist

1.45
-1.55-51.67%

15min DelayClose Nov 29 13:00 ET

2.65High1.45Low

Intraday

5D
Daily

News

Baird Maintains Soleno Therapeutics(SLNO.US) With Buy Rating, Maintains Target Price $72
Moomoo NewsNov 29 19:31 ET · Ratings
Soleno Therapeutics to Participate in Piper Sandler 36th Annual Healthcare Conference
GlobeNewswireNov 27 08:00 ET
Soleno Therapeutics Says FDA Extends DCCR NDA Review Citing 'Major Amendment'
MT NewswiresNov 26 09:03 ET
Express News | Soleno Therapeutics Shares Slide 13% Premarket After Co Announces US FDA Extension of Review Period for Genetic Disorder Treatment
ReutersNov 26 08:38 ET
Soleno Therapeutics Announces U.S.. FDA to Ended Review Period for NDA
TipRanksNov 26 08:35 ET
Express News | Soleno: FDA Determined That Responses to Recent Information Requests Constituted a Major Amendment to Nda for Dccr Extended-Release Tablets
ReutersNov 26 08:30 ET

Comments

Meltyy

May 16 01:29

🔔 Perceptive Advisors Q1 ‘24* Holdings Released... 🐳

» Holdings: 112
» Holdings in Top 20: 58.46%
» Qtr over Qtr Change**: 28.47%
Top Holdings:
$Cerevel Therapeutics Holdings (CERE.US)$
$Amicus Therapeutics (FOLD.US)$
$Iovance Biotherapeutics (IOVA.US)$
$Arcellx (ACLX.US)$
$Nuvalent (NUVL.US)$
$Apogee Therapeutics (APGE.US)$
$Inhibrx (INBX.US)$
$Fusion Pharmaceuticals (FUSN.US)$
$Rhythm Pharmaceuticals (RYTM.US)$
$Vaxcyte (PCVX.US)$
$Soleno Therapeutics (SLNO.US)$
$Medtronic (MDT.US)$
$Madrigal Pharmaceuticals (MDGL.US)$
...

Moomoo AI

Mar 8 06:55

Despite the increase in cash burn, the company's solid cash runway and the analysts' forecast of reaching breakeven point suggest a positive outlook. The company's cash burn relative to its market capitalisation, which is US$1.4b, is about 1.7%, indicating that it could potentially raise more cash easily if needed.

We're Interested To See How Soleno Therapeutics (NASDAQ:SLNO) Uses Its Cash Hoard To Grow

Joy Boy or Bringer

Dec 29, 2023 22:42

More reason to study biotech

From small cap to big cap, it is interesting.
Now they have a way to treat diabetes, obesity. I believe later they will find a way to cure cancer, Alzheimer and other disease not just treat it and prevent it.
To clone something is unreal before, even travel to mars is real now. ( $Virgin Galactic (SPCE.US)$
thank you for wonderful run $Tempest Therapeutics (TPST.US)$ $Soleno Therapeutics (SLNO.US)$ $Arcutis Biotherapeutics (ARQT.US)$ $2seventy bio (TSVT.US)$ $Redhill Biopharma (RDHL.US)$ etc... th...

BrandonnW

Dec 28, 2023 02:03

The 2023 U.S. stock rally champion is out, and it's not Nvidia or Tesla

Is it Nvidia, the maker of chips related to artificial intelligence? This is despite the fact that the stock has soared more than 200% this year. Other big tech stocks like Apple are up nearly 50% this year, Microsoft is up about 56%, Google parent Alphabet's Class A and Class C shares are up nearly 60% each, Amazon is up more than 80%, Tesla has doubled more than doubled, and Meta almost tripled.
However, none of these stoc...

WeiTheSaint469

Dec 16, 2023 20:03

dang that cant be good. selling 87% of his shares.

$Soleno Therapeutics (SLNO.US)$